West Pharmaceutical Services, Inc. (WST)
USD 325.32
(-2.67%)
USD 325.32
(-2.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 776.5 Million | 724 Million | 584 Million | 472.5 Million | 367.2 Million | 288.6 Million |
| Net Income | 593.4 Million | 585.9 Million | 661.8 Million | 346.2 Million | 241.7 Million | 206.9 Million |
| Depreciation & Amortization | 137.3 Million | 120.6 Million | 122.3 Million | 109.1 Million | 103.4 Million | 104.4 Million |
| Deferred income taxes | 37.5 Million | -30.8 Million | -42.9 Million | -5.8 Million | 15.3 Million | 900 Thousand |
| Stock-based compensation | 23.3 Million | 23.7 Million | 37.5 Million | 34 Million | 24.4 Million | 15.1 Million |
| Change in working capital | -20.4 Million | -11.5 Million | -193.8 Million | -10.3 Million | -14.4 Million | -28.3 Million |
| Other non-cash items | 5.4 Million | 36.1 Million | -900 Thousand | -700 Thousand | -3.2 Million | -10.4 Million |
| Investing Cash Flow | -368.7 Million | -288.2 Million | -253.1 Million | -179.5 Million | -228 Million | -100.8 Million |
| Investments in PPE | -362 Million | -284.6 Million | -253.4 Million | -174.4 Million | -126.4 Million | -104.7 Million |
| Acquisitions | - | - | -2.2 Million | - | -104 Million | - |
| Investment purchases | - | - | - | - | -85.1 Million | - |
| Sales/Maturities of investments | - | - | - | - | 85.1 Million | - |
| Other Investing Activities | -6.7 Million | -3.6 Million | 2.5 Million | -5.1 Million | 2.4 Million | 3.9 Million |
| Financing Cash Flow | -459.6 Million | -293.6 Million | -168.1 Million | -137.1 Million | -36.8 Million | -80.7 Million |
| Debt repayment | -2.3 Million | -44.3 Million | -2.2 Million | -2.3 Million | -136.4 Million | -100 Thousand |
| Dividends payments | -57 Million | -54.1 Million | -51.1 Million | -48.1 Million | -45.1 Million | -42.1 Million |
| Common Stock Repurchased | -451.2 Million | -222.2 Million | -151.9 Million | -115.5 Million | -83.1 Million | -75.2 Million |
| Common Stock Issuance | 51 Million | 28.2 Million | 37.1 Million | 28.8 Million | 229 Million | 31.8 Million |
| Other Financing Activities | -100 Thousand | -1.2 Million | -14.8 Million | -89 Million | -1.2 Million | 36.7 Million |
| Accounts receivables | 4 Million | -35.6 Million | -123.5 Million | -46.6 Million | -33.3 Million | -43.8 Million |
| Accounts payables | 4.4 Million | -2.8 Million | 16.8 Million | 36.6 Million | 25.3 Million | 400 Thousand |
| Inventory | -13.5 Million | -49.8 Million | -86.5 Million | -73.7 Million | -18.6 Million | -7 Million |
| Other working capital | -15.3 Million | 76.7 Million | -600 Thousand | 73.4 Million | 12.2 Million | 22.1 Million |
| Cash at beginning of period | 894.3 Million | 762.6 Million | 615.5 Million | 439.1 Million | 337.4 Million | 235.9 Million |
| Cash at end of period | 853.9 Million | 894.3 Million | 762.6 Million | 615.5 Million | 439.1 Million | 337.4 Million |
| Capital Expenditure | -362 Million | -284.6 Million | -253.4 Million | -174.4 Million | -126.4 Million | -104.7 Million |
| Effect of forex changes on cash | 11.4 Million | -10.5 Million | -15.7 Million | 20.5 Million | -700 Thousand | -5.6 Million |
| Net cash flow / Change in cash | -40.4 Million | 131.7 Million | 147.1 Million | 176.4 Million | 101.7 Million | 101.5 Million |
| Free Cash Flow | 414.5 Million | 439.4 Million | 330.6 Million | 298.1 Million | 240.8 Million | 183.9 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 136 Million | 111.3 Million | 115.3 Million | 593.4 Million | 137 Million | 161.3 Million |
| Depreciation & Amortization | 40.2 Million | 38.9 Million | 35.6 Million | 137.3 Million | 35.9 Million | 35.7 Million |
| Deferred income taxes | - | - | - | 37.5 Million | 23.4 Million | -192 Million |
| Stock-based compensation | 5.1 Million | 4.3 Million | 5 Million | 23.3 Million | 1.4 Million | 5.9 Million |
| Change in working capital | -100 Thousand | 14.1 Million | -34.6 Million | -20.4 Million | 26.9 Million | 24.8 Million |
| Other non-cash items | -1.1 Million | 78.5 Million | -3.7 Million | 5.4 Million | 14.5 Million | 194.4 Million |
| Investing Cash Flow | -82.1 Million | -101.2 Million | -90.6 Million | -368.7 Million | -108.8 Million | -95.7 Million |
| Investments in PPE | -81.3 Million | -100.2 Million | -90.6 Million | -362 Million | -108.7 Million | -95.8 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -82.1 Million | -1 Million | - | -6.7 Million | -100 Thousand | 100 Thousand |
| Financing Cash Flow | -64.4 Million | -218.3 Million | -271 Million | -459.6 Million | -189.5 Million | -22.3 Million |
| Debt repayment | -3.5 Million | -23.4 Million | -600 Thousand | -2.3 Million | -600 Thousand | -600 Thousand |
| Dividends payments | -14.5 Million | -14.6 Million | -14.7 Million | -57 Million | -14.8 Million | -14 Million |
| Common Stock Repurchased | -52.4 Million | -187.1 Million | -272.4 Million | -451.2 Million | -177.1 Million | -28.1 Million |
| Common Stock Issuance | -23.6 Million | 6.8 Million | 16.8 Million | 51 Million | 3.1 Million | 20.4 Million |
| Other Financing Activities | 6 Million | 41.9 Million | -100 Thousand | -100 Thousand | -100 Thousand | -300 Thousand |
| Accounts receivables | - | - | - | 4 Million | 4 Million | - |
| Accounts payables | - | - | - | 4.4 Million | 9.5 Million | - |
| Inventory | - | - | - | -13.5 Million | -13.5 Million | - |
| Other working capital | -100 Thousand | 14.1 Million | -34.6 Million | -15.3 Million | 26.9 Million | 24.8 Million |
| Cash at beginning of period | 446.2 Million | 601.8 Million | 853.9 Million | 894.3 Million | 898.6 Million | 796.3 Million |
| Cash at end of period | 490.9 Million | 446.2 Million | 601.8 Million | 853.9 Million | 853.9 Million | 230.1 Million |
| Capital Expenditure | -81.3 Million | -100.2 Million | -90.6 Million | -362 Million | -108.7 Million | -95.8 Million |
| Effect of forex changes on cash | 11.1 Million | -1.1 Million | -8.7 Million | 11.4 Million | 14.5 Million | -9.8 Million |
| Net cash flow / Change in cash | 44.7 Million | -155.6 Million | -252.1 Million | -40.4 Million | -44.7 Million | -566.2 Million |
| Free Cash Flow | 98.8 Million | 64.8 Million | 27.6 Million | 414.5 Million | 130.4 Million | 134.3 Million |
HIHI
0301
6780
DEEPENR
MONTECARLO
CWX